A detailed history of Virtus ETF Advisers LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 9,739 shares of REPL stock, worth $140,046. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,739
Previous 9,569 1.78%
Holding current value
$140,046
Previous $86,000 23.26%
% of portfolio
0.05%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.09 - $11.23 $1,375 - $1,909
170 Added 1.78%
9,739 $106,000
Q2 2024

Aug 14, 2024

SELL
$5.01 - $9.46 $7,995 - $15,098
-1,596 Reduced 14.29%
9,569 $86,000
Q1 2024

May 15, 2024

SELL
$6.87 - $9.31 $5,262 - $7,131
-766 Reduced 6.42%
11,165 $91,000
Q4 2023

Feb 15, 2024

BUY
$6.75 - $16.18 $52,076 - $124,828
7,715 Added 182.99%
11,931 $100,000
Q3 2023

Nov 07, 2023

SELL
$15.96 - $22.18 $6,623 - $9,204
-415 Reduced 8.96%
4,216 $72,000
Q2 2023

Aug 14, 2023

BUY
$15.65 - $24.1 $15,775 - $24,292
1,008 Added 27.82%
4,631 $107,000
Q1 2023

May 15, 2023

SELL
$17.48 - $29.09 $24,402 - $40,609
-1,396 Reduced 27.81%
3,623 $63,000
Q4 2022

Feb 14, 2023

SELL
$17.09 - $27.91 $36,470 - $59,559
-2,134 Reduced 29.83%
5,019 $136,000
Q3 2022

Nov 14, 2022

BUY
$15.6 - $21.15 $702 - $951
45 Added 0.63%
7,153 $124,000
Q2 2022

Aug 12, 2022

BUY
$13.32 - $19.98 $19,460 - $29,190
1,461 Added 25.87%
7,108 $124,000
Q1 2022

May 16, 2022

SELL
$15.24 - $29.75 $5,166 - $10,085
-339 Reduced 5.66%
5,647 $96,000
Q4 2021

Feb 14, 2022

SELL
$25.43 - $34.25 $3,763 - $5,069
-148 Reduced 2.41%
5,986 $162,000
Q3 2021

Nov 15, 2021

SELL
$28.98 - $39.54 $9,215 - $12,573
-318 Reduced 4.93%
6,134 $182,000
Q2 2021

Aug 10, 2021

SELL
$28.5 - $39.37 $12,397 - $17,125
-435 Reduced 6.32%
6,452 $248,000
Q1 2021

May 17, 2021

BUY
$30.22 - $45.57 $3,565 - $5,377
118 Added 1.74%
6,887 $210,000
Q4 2020

Feb 12, 2021

BUY
$23.5 - $52.65 $159,071 - $356,387
6,769 New
6,769 $258,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $709M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.